Skip to main content
DealProspect/Listings/Healthcare

Medical Diagnostics Technology Investment

ActiveHealthcareNew South WalesB2B & B2C
Asking price
$5,000,000
Disclosed · AUD
Revenue
EBITDA (est.)
~$1,481,481
Estimated · comparable listings of this type and size
Implied multiple (assumed)
~3.4×
Assumed · asking ÷ estimated EBITDA
Brief
  • Multi-patented, non-invasive medical diagnostics technology developed over two decades of R&D
  • Breath-based sensor approach positioned as an alternative to blood tests, imaging and biopsies
  • Internal research indicates capability to diagnose a wide range of respiratory, cancer, metabolic and other conditions
  • AI-driven software claims over 95% diagnostic accuracy
  • Structured as a capital raise to fund large-scale clinical trials and regulatory approval
  • Regulatory pathways targeted include the FDA, EMA and TGA